Merrimack Pharmaceuticals Inc (MACK)
6.23
-0.02 -0.32%
NASDAQ
May 24, 20:00
Delayed 2m
USD
View All Key Stats
MACK Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -2.47 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -33.18M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 83.13M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 83126.89 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 1.698 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | -13.65M |
| Return on Equity (TTM) | Upgrade |
View All MACK News
MACK News
-
WireHeadlineTime (ET)
-
SA Breaking News05/10 07:39
-
PR Newswire05/10 07:30
-
Yahoo05/06 13:46
-
Yahoo05/03 17:43
-
MT Newswires04/30 15:55
-
SA Breaking News04/30 09:24
-
Globe Newswire04/18 15:07
-
Yahoo04/16 16:15
-
Globe Newswire04/16 07:10
-
Globe Newswire04/12 13:57
View All Events
MACK Events
| Date | Type | Description |
|---|---|---|
| 08/07/2019 08:30 EDT | Misc | Merrimack Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2019 |
| 08/07/2019 | Earnings | Merrimack Pharmaceuticals Inc Second Quarter Earnings in 2019 Release |
| 05/10/2019 | Earnings | Merrimack Pharmaceuticals Inc First Quarter Earnings Results in 2019 |
| 03/06/2019 | Earnings | Merrimack Pharmaceuticals Inc Fourth Quarter Earnings in 2018 Release |
| 11/07/2018 08:30 EST | Misc | Merrimack Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2018 |
| 11/07/2018 | Earnings | Merrimack Pharmaceuticals Inc Third Quarter Earnings in 2018 Release |
| 08/07/2018 08:30 EDT | Misc | Merrimack Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2018 |
| 08/07/2018 | Earnings | Merrimack Pharmaceuticals Inc Second Quarter Earnings Results in 2018 |
| 06/12/2018 16:00 EDT | Misc | Merrimack Pharmaceuticals Inc Annual General Meeting in 2017 |
MACK Fundamentals
Income Statement View Statement
MACK Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
MACK One Page Reports
- One Page Report Download
Edit
Profile
- URL: http://www.merrimack.com
- Investor Relations URL: http://investors.merrimackpharma.com/
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Blend
- Next Earnings Release: Aug. 07, 2019
- Last Earnings Release: May. 10, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: May. 30, 2017
- Description: Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products.
MACK Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 6.23 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Excel Add-In Codes
- Name: =YCI("MACK","name")
- Description: =YCI("MACK","description")
- Sector: =YCI("MACK","sector")
- Industry: =YCI("MACK","industry")
- Est. Current Fiscal Year End: =YCI("MACK","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other MACK Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- MACK Tweets Stocktwits
Advertisement
